Sumitomo Pharma (TKS: 4506)

Sumitomo Pharma is a corporation based in Osaka, Japan. Established in 1897, the company engages in the development of medicines to improve the health and lives of people. It is involved in conducting clinical development projects in therapeutic areas of the central nervous system, diabetes and cardiovascular inflammation, and allergy. The assets of the company are managed by the executive management team.